Heart and kidney disease: a cardiovascular high-risk constellation

Stefan J Schunk1,2, Thimoteus Speer3,4, Danilo Fliser3

  • 1Klinik für Innere Medizin IV, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. stefan.schunk@uks.eu.

Herz
|December 30, 2020
PubMed

Insights

Chronic kidney disease (CKD) patients face high cardiovascular risks from traditional factors like hypertension and diabetes, alongside CKD-specific issues. Managing these risks is crucial for preventing heart disease in CKD care.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Chronic kidney disease (CKD) significantly increases cardiovascular morbidity and mortality.
  • Patients with CKD often have traditional cardiovascular risk factors like hypertension and diabetes.
  • CKD is also linked to non-traditional risk factors including vascular calcification, uremic toxins, inflammation, and oxidative stress.

Purpose of the Study:

  • To highlight the importance of cardiovascular disease prevention in CKD management.
  • To outline strategies for primary and secondary prevention of cardiovascular events in CKD patients.

Main Methods:

  • Review of existing literature on cardiovascular risk factors in CKD.
  • Analysis of management strategies for traditional and non-traditional risk factors.

Main Results:

  • Optimal control of blood pressure and diabetes is essential.
  • Treatment of uremic dyslipidemia is a key intervention.
  • Lifestyle modifications such as weight reduction and smoking cessation are important.

Conclusions:

  • Comprehensive management of cardiovascular risk factors is vital for CKD patient outcomes.
  • Addressing both traditional and non-traditional risk factors improves cardiovascular health in CKD.
  • Integrated care focusing on blood pressure, diabetes, dyslipidemia, and lifestyle is recommended.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
354
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
156
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.7K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
616
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
673
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K